Century Therapeutics, Inc. (IPSC) Free cash flow 2020–2025
Century Therapeutics, Inc. (IPSC) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$104.7MFY2025 · since FY2020: -$51.1M → -$104.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$104.7M | +5.0% |
| FY2024 | -$110.3M | -8.0% |
| FY2023 | -$102.1M | -516.7% |
| FY2022 | -$16.6M | +87.6% |
| FY2021 | -$134.0M | -162.2% |
| FY2020 | -$51.1M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More IPSC financial trends
IPSC RevenueIPSC Net incomeIPSC Net marginIPSC Gross profitIPSC Gross marginIPSC Operating incomeIPSC Operating marginIPSC Operating cash flowIPSC Capital expendituresIPSC Return on equityIPSC Stock buybacksIPSC Dividends paidIPSC Total assetsIPSC Total liabilitiesIPSC Shareholders’ equityIPSC overview →